Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
Article in Nature Immunology (October 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy
Article in Cancer Gene Therapy (July 2023)
A disintegrin and metalloprotease 12 contributes to colorectal cancer metastasis by regulating epithelial-mesenchymal transition
Article in International Journal of Oncology (March 2023)